Cancer guide
By Cura Editorial Team ·
Aggressive and often diagnosed late — early treatment at a high-volume center and genetic testing meaningfully change outcomes.
Early signs, which ones need a same-week doctor visit, and what screening looks like.
Read the symptoms guideThe questions that shape treatment — biomarkers, staging, surgery, chemo, second opinions.
Read the questions guideRecent approvals and trial results — and the questions to ask your oncologist about whether any of it applies to you. Not every option fits every person.
In the phase 3 RASolute 302 trial, the daily pill daraxonrasib extended median survival to 13.2 months, compared with about 6.7 months on chemotherapy, in previously treated metastatic pancreatic cancer.
May apply to: Previously treated metastatic pancreatic cancer
Ask your oncologist:
Source: NEJM
The FDA approved daraxonrasib (Rasonque) for metastatic pancreatic cancer after prior treatment, or for people who can't tolerate combination chemotherapy.
May apply to: Metastatic pancreatic adenocarcinoma
Ask your oncologist:
Source: FDA
Reviewed September 25, 2026.
Email me when something new is approved for pancreatic cancer
Only real treatment news for this cancer, in plain language. Optional — the guide and Ask Cura stay free and anonymous. Unsubscribe anytime.
The signs that most often lead to a pancreatic cancer diagnosis are: painless jaundice (yellowing of skin or eyes) — same-day evaluation; new-onset diabetes after 50 without obvious cause; persistent upper abdominal or mid-back pain, unexplained weight loss. Any of these lasting more than a couple of weeks is worth a same-week appointment, even though most turn out to be something else.
See a doctor promptly if a symptom is new, persistent, or getting worse rather than better. Describe when it started, how often it happens, and what makes it better or worse — that detail is what decides whether you get imaging or testing at the first visit.
Aggressive and often diagnosed late — early treatment at a high-volume center and genetic testing meaningfully change outcomes. High-volume centers (50+ Whipple procedures per year) have better outcomes. BRCA1/2 and PALB2 testing can open targeted therapy and trial options. Neoadjuvant chemotherapy before surgery is now common.
Ask what the exact diagnosis is and how it is staged, what the treatment options are and in what order they would happen, what the goal of treatment is, which side effects to expect, and whether a second opinion or clinical trial makes sense for your situation.
Paste a pathology report, upload a scan summary, or just type the question you'd ask your oncologist if you had more than 15 minutes. Cura will answer in plain language.
Ask CuraWant occasional plain-language health explainers?
A short note now and then. No spam, unsubscribe anytime.
If a start date is on the calendar, or you feel lost between diagnosis and the first infusion, build a first-visit brief on the page: what's known, what's missing, what to ask. Homework, not a treatment plan.
Cura Brief is educational. It is not medical advice, a diagnosis, or a treatment plan. Confirm everything with your oncology team. If this is an emergency, call emergency services. Email is not an emergency line.
Prefer email? hello@curawellplan.com
Waiting for results is its own kind of hard. Cura has a plain-language guide to what the wait actually means — and what to do while you wait.
How long do biopsy results take?